RayzeBio Revenue and Competitors

Claim your profile



Growjo Ranking



Estimated Revenue & Valuation

  • RayzeBio's estimated annual revenue is currently $9.6M per year.(i)
  • RayzeBio's estimated revenue per employee is $133,472
  • RayzeBio's total funding is $258M.

Employee Data

  • RayzeBio has 72 Employees.(i)
  • RayzeBio grew their employee count by 118% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

Leader in targeted radiopharmaceuticals to improving cancer patient survival. Broad pipeline of innovative drugs against solid tumor targets



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





RayzeBio News

2021-06-16 - RayzeBio Snags $108M for Cancer Drug Efforts

San Diego-based RayzeBio, a pharmaceuticals company which says it is developing targeted radiopharmaceutical drugs for cancer, has raised $108M in its Series C funding. The company said it has now raised a total of $258M. The new funding was led by Venrock Healthcare Capital Partners and also in ...

2021-06-15 - RayzeBio Secures $108 Million Series C Financing to Drive Forward Its Pipeline of Targeted Radiopharmaceuticals for Cancer

RayzeBio, Inc., which is discovering and developing a broad pipeline of innovative targeted radiopharmaceutical drugs for cancer, today announced a $108 million Series C financing led by Venrock Healthcare Capital Partners alongside new investors Perceptive Advisors, Vivo Capital, Acuta Capital ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding